Cargando…

Is there a role of lipid-lowering therapies in the management of fatty liver disease?

Atherogenic dyslipidemia is characterized by increased triglyceride-rich lipoproteins and low high-density lipoprotein cholesterol concentrations. It is highly prevalent in non-alcoholic fatty liver disease (NAFLD) and contributes to the increased cardiovascular risk associated with this condition....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzanaki, Ismini, Agouridis, Aris P, Kostapanos, Michael S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790403/ https://www.ncbi.nlm.nih.gov/pubmed/35126843 http://dx.doi.org/10.4254/wjh.v14.i1.119

Ejemplares similares

The Effect of Statins on Ocular Disorders: A Systematic Review of Randomized Controlled Trials
por: Lymperopoulou, Charoula, et al.
Publicado: (2023)

An overview of lipid abnormalities in patients with inflammatory bowel disease
por: Agouridis, Aris P., et al.
Publicado: (2011)

Characterization and Roles of Membrane Lipids in Fatty Liver Disease
por: Welch, Morgan, et al.
Publicado: (2022)

The Effect of Upadacitinib on Lipid Profile and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials
por: Makris, Anastasios, et al.
Publicado: (2022)

Safety Profile of Niraparib as Maintenance Therapy for Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Pagkali, Antonia, et al.
Publicado: (2022)

Role of Lipid-Lowering Therapy in Peripheral Artery Disease
por: Belur, Agastya D., et al.
Publicado: (2022)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Playing Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver Disease
por: Molenaar, Martijn R., et al.
Publicado: (2020)

Role of Colesevelam in Combination Lipid-Lowering Therapy
por: Jones, Michael R., et al.
Publicado: (2013)

The Effect of Statins on the Incidence and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis
por: Symvoulidis, Panagiotis, et al.
Publicado: (2023)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Expanding Pharmacists’ Role in the Management of Non-Alcoholic Fatty Liver Disease
por: Syed-Abdul, Majid Mufaqam
Publicado: (2023)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023)

The Future of Lipid-Lowering Therapy
por: van Zwol, Willemien, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Lomentospora prolificans Disseminated Infections: A Systematic Review of Reported Cases
por: Konsoula, Afroditi, et al.
Publicado: (2022)

Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
por: Makris, Anastasios, et al.
Publicado: (2023)

Ear lobe crease: a marker of coronary artery disease?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Appropriate antimicrobial use during the COVID-19 pandemic: not cause for complacency
por: Spernovasilis, Nikolaos, et al.
Publicado: (2023)

Lomentospora prolificans: An Emerging Opportunistic Fungal Pathogen
por: Konsoula, Afroditi, et al.
Publicado: (2022)

Combination Therapies for Nonalcoholic Fatty Liver Disease
por: Makri, Evangelia S., et al.
Publicado: (2022)

MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease
por: Yu, Jingwei, et al.
Publicado: (2019)

Targeted Strategy in Lipid-Lowering Therapy
por: Dayar, Ezgi, et al.
Publicado: (2022)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
por: Frasinariu, Otilia, et al.
Publicado: (2022)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

Dysfunctional high-density lipoprotein: not only quantity but first of all quality?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2022)

The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review
por: Lavallee, Celeste M., et al.
Publicado: (2022)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)

SUN-550 CARF Through Its Lipid Lowering Effect May Play a Pivotal Role in the Development of Non-Alcoholic Fatty Liver Diseases
por: Hasan, Kamrul M, et al.
Publicado: (2020)

The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
por: Chambel, Sílvia S., et al.
Publicado: (2015)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Lipid-lowering therapy: who can benefit?
por: Lewis, Sandra J
Publicado: (2011)

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
por: Desai, Nihar R., et al.
Publicado: (2022)

The Role of Non-Alcoholic Fatty Liver Disease in Infections
por: Krznarić, Juraj, et al.
Publicado: (2022)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tef1a28r8e3cj0e7nl2r4utaur